home / stock / iccc / iccc news


ICCC News and Press, ImmuCell Corporation From 04/07/24

Stock Information

Company Name: ImmuCell Corporation
Stock Symbol: ICCC
Market: NASDAQ
Website: immucell.com

Menu

ICCC ICCC Quote ICCC Short ICCC News ICCC Articles ICCC Message Board
Get ICCC Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCC - Long Term Trading Analysis for (ICCC)

2024-04-07 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ICCC - ImmuCell files for $20M mixed shelf offering

2024-04-02 10:38:15 ET More on ImmuCell ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript Financial information for ImmuCell Read the full article on Seeking Alpha For further details see: ImmuCell files for $20M mixed shelf offering

ICCC - (ICCC) Investment Analysis and Advice

2024-03-28 19:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ICCC - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - Expected US Company Earnings on Tuesday, February 27th, 2024

First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...

ICCC - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

PORTLAND, Maine, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - ImmuCell says total sale for year ended December falls 6% Y/Y

2024-01-08 16:35:05 ET More on ImmuCell ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript Financial information for ImmuCell For further details see: ImmuCell says total sale for year ended December falls 6% Y/Y

ICCC - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023

PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...

ICCC - ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript

2023-11-14 14:36:22 ET ImmuCell Corporation (ICCC) Q3 2023 Earnings Conference Call November 14, 2023, 09:00 ET Company Participants Joe Diaz - Managing Partner; Lytham Partners, LLC Michael Brigham - CEO Conference Call Participants Presentation ...

ICCC - ImmuCell GAAP EPS of -$0.12, revenue of $5.39M

2023-11-13 16:23:32 ET More on ImmuCell Financial information for ImmuCell For further details see: ImmuCell GAAP EPS of -$0.12, revenue of $5.39M

Previous 10 Next 10